Literature DB >> 23666699

Molecular detection of t(14;18)(q32;q21) in follicular lymphoma.

C Cameron Yin1, Rajyalakshmi Luthra.   

Abstract

The t(14;18)(q32;q21) can be detected in approximately 80% of cases of follicular lymphoma (FL). This translocation juxtaposes the BCL2 oncogene at 18q21 with the IGH@ at 14q32, and leads to overexpression of BCL2 protein which protects the cells from apoptosis. The high degree of sequence homology among the 3' portion of the JH segments and the clustering of breakpoints on chromosome 18 make the IGH@/BCL2 very amenable to polymerase chain reaction (PCR) detection. We describe two multiplex TaqMan-based real-time PCR assays which can be used to detect and quantify the major and minor breatpoint cluster regions of IGH@/BCL2 fusion products in newly diagnosed FL, and to monitor minimal residual disease during treatment or early relapse.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23666699     DOI: 10.1007/978-1-62703-357-2_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases.

Authors:  Yu Li; Shimin Hu; Zhuang Zuo; Ming Hong; Pei Lin; Shaoying Li; Sergej Konoplev; Zhen Wang; Joseph D Khoury; Ken H Young; L Jeffrey Medeiros; C Cameron Yin
Journal:  Mod Pathol       Date:  2015-03-06       Impact factor: 7.842

2.  A capture-sequencing strategy identifies IRF8, EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma.

Authors:  Hakim Bouamar; Saman Abbas; An-Ping Lin; Long Wang; Daifeng Jiang; Kenneth N Holder; Marsha C Kinney; Scott Hunicke-Smith; Ricardo C T Aguiar
Journal:  Blood       Date:  2013-06-17       Impact factor: 22.113

Review 3.  Notch signaling: its roles and therapeutic potential in hematological malignancies.

Authors:  Yisu Gu; Massimo Masiero; Alison H Banham
Journal:  Oncotarget       Date:  2016-05-17

4.  Autocrine-based selection of ligands for personalized CAR-T therapy of lymphoma.

Authors:  Alexey V Stepanov; Oleg V Markov; Ivan V Chernikov; Daniil V Gladkikh; Hongkai Zhang; Teresa Jones; Alexandra V Sen'kova; Elena L Chernolovskaya; Marina A Zenkova; Roman S Kalinin; Maria P Rubtsova; Alexander N Meleshko; Dmitry D Genkin; Alexey A Belogurov; Jia Xie; Alexander G Gabibov; Richard A Lerner
Journal:  Sci Adv       Date:  2018-11-14       Impact factor: 14.136

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.